Acro Biomedical Co., Ltd.
ACBM OTC
SEC CIK 1622996
Follow Acro Biomedical Co., Ltd.
Weekly email: filings, results, news
Revenue, last quarter
$0
Net income
−$21.4K
−37.2% vs same quarter last year
EPS, diluted
$0.00
Operating cash flow
−$10.5K
+88.8% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $0 | −$101.1K |
| FY24 | $0 | −$42.3K |
| FY23 | $0 | −$8.8M |
| FY22 | $658.5K | −$15.9M |
| FY21 | $1.2M | −$7.7M |
| FY20 | $688K | −$117.5K |
| FY19 | $193.5K | −$371.6K |
| FY18 | $8M | $419.7K |
| FY17 | $510K | −$2.2K |
| FY16 | - | −$43.4K |
| FY15 | - | −$47.5K |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | - | - | - |
| FY24 | - | - | - |
| FY23 | - | - | - |
| FY22 | 21.3% | −2410% | −2410.2% |
| FY21 | 21.7% | −642.5% | −642.8% |
| FY20 | 23.2% | −19% | −17.1% |
| FY19 | 6.2% | −218.4% | −192% |
| FY18 | 10.4% | 6.4% | 5.2% |
| FY17 | 10% | −0.4% | −0.4% |
| FY16 | - | - | - |
| FY15 | - | - | - |
- Acro Biomedical Co., Ltd.
- Consumer median
Show the numbers
| Year | Acro Biomedical Co., Ltd. | Consumer median |
|---|---|---|
| FY25 | - | 2.3% |
| FY24 | - | 3.4% |
| FY23 | - | 2.7% |
| FY22 | −2410.2% | 3.8% |
| FY21 | −642.8% | 2.9% |
| FY20 | −17.1% | 1.9% |
| FY19 | −192% | 2.6% |
| FY18 | 5.2% | 3% |
| FY17 | −0.4% | 2.6% |
| FY16 | - | 3.2% |
| FY15 | - | 3.4% |
News
No stories filed under Acro Biomedical Co., Ltd. yet - coverage appears here as the news feed clusters it.